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Abstract. Mice homozygous for the nb mutation
(Chromosome 8) have a severe hemolytic anemia and
develop a psychomotor disorder at 6 mo of age. The
nblnb mice are deficient in erythroid ankyrin (Ank-1)
but, until the present study, the role of Ank-1 and of
Ank-2 (brain ankyrin) in disease genesis was un-
known. In normal erythroid tissues, we show that two
major transcripts are expressed from Ank1, and one of
these is also present at high levels in the cerebellum.
By in situ hybridization and immunocytochemistry,
Ank-1 localizes to the cerebellar Purkinje cells and, to
S
PECTRIN is the major component of the erythrocyte
cytoskeleton (for reviews, see Bennett, 1990 ; Carra-
way and Carraway, 1989). Erythrocyte strength, stabil-
ity, and viscoelastic properties are directly related to spectrin
content (Waugh and Agre, 1988; Chasis et al., 1988). Anky-
rin provides the major link between this spectrin-based
membrane skeleton and the erythrocyte plasma membrane
through high-affinity binding sites for beta spectrin and the
cytoplasmic domain of Band 3 (Bennett and Stenbuck,
1980). Binding of the peripheral membrane protein 4 .2
to ankyrin stabilizes the attachmentof ankyrin to the eryth-
rocyte plasma membrane (Korsgren and Cohen, 1988; Ry-
bicki et al ., 1988). In view of the pivotal role ankyrin plays
in linking spectrin to the plasma membrane, its importance
in maintaining erythrocyte integrity is easily appreciated.
Ankyrin-deficient hemolytic anemias have been described in
both mice (normoblastosis, gene symbol nb) and humans
(Hereditary spherocytosis-2, gene symbol SPH-1) (Bodine et
al ., 1984 ; Costa et al ., 1990; Lux et al ., 1990a; Hanspal et
al ., 1991) .
Immunoreactive forms of ankyrin have been found in
many tissues including the brain (Davis and Bennett, 1984),
kidney (Drenckhahn and Bennett, 1987), liver and testis
(Bennett, 1979), the eye (Allen et al., 1987), and at the
nodes of Ranvier (Kordeli et al., 1990). Ankyrin also binds
such integral membrane proteins as the Na+K+ ATPase
(Morrow et al ., 1989) and the voltage-dependent Na+ chan-
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a lesser extent, the granule cells. In nblnb mice, Ank1
transcripts are markedly reduced in both erythroid and
neural tissue, and nblnb Purkinje cells and granule
cells are nearly devoid of Ank-1. The neurological syn-
drome appears concurrently with a dramatic loss of
Purkinje cells. Ank-2 maps to Chromosome 3 and its
expression is unaffected by the nb mutation. We con-
clude that Ank-1 is specifically required for Purkinje
cell stability and, in its absence, Purkinje cell loss and
neurological symptoms appear.
nels (Srinivasan et al., 1988). The colocalization of ankyrin
with these integral membrane proteins at restricted sites in
kidney tubules and neurons suggests that ankyrin bindsthese
proteins to the plasma membrane and is important in the es-
tablishment of membrane polarity (Bennett, 1990; Morrow
et al ., 1989 ; Srinivasan et al., 1988).
The exact number of genes involved in the production of
the tissue immunoreactive ankyrins is not known. Two anky-
rins have been cloned, sequenced, and mapped in the hu-
man. ANKI is the major variety in the human erythrocyte
cytoskeleton and maps to chromosome 8 in both the human
(Lux et al., 1990b ; Lambert et al ., 1990) and the mouse
(White et al., 1990) . The major form of ankyrin found in the
brain (ANK-2) shares many physical and biochemical prop-
erties with Ank-1 (Davis and Bennett, 1984). It is encoded,
however, by a structurally distinct gene, ANK-2 (Otto et al.,
1991), and maps to humanchromosome 4q (Tse, W. T., per-
sonal communication). The present report establishes the lo-
cation ofAnk-2 on murine Chromosome 3. Recent evidence
suggests that the ankyrin present at the nodes of Ranvier
represents a gene product distinct from ANKI and ANK2
(Kordeli and Bennett, 1991). Whether the ankyrins found
elsewhere are products of distinct genes or are alternatively
spliced products of ANKI and ANK2 is not yet known.
Mice carrying the normoblastosis mutation have provided
a useful model for establishing the effects of ankyrin de-
ficiency upon the red blood cell membrane (Bodine et al.,1984; White et al., 1990). We have found that, in addition
to the hemolytic anemia, these mice develop an age-related
neurological syndrome characterized by a persistent tremor
and an awkward gait. In this report, we establish the relation-
ship between Ank-1, Ank-2 and the neurological symptoms
noted in the severely anemic nb/nb mice. We have demon-
strated that Ank-1 is present in the cerebellum of normal
mice and localizes to the Purkinje and granule cells, deter-
mined that Ank1 transcripts and erythroid ankyrin are se-
verely reduced in nb/nb tissues and discovered an extensive
loss of mutant Purkinje cells with time. We have further
shown that Ank-2 maps to Chromosome 3 and its expression
is unaffected by the nb mutation. Hence, we conclude that
Ank-1, erythroid ankyrin, plays a vital role in the stabiliza-
tion of murine Purkinje cells, as well as of erythrocytes, and
that its role in humans with SPH-1 should be investigated .
Materials andMethods
Animals
All mice were produced in our research colony at The Jackson Laboratory
which is fully accreditedby the AmericanAssociation forthe Accreditation
of Laboratory Animal Care. The nb mutation was maintained in the hetero-
zygous state on both the WB/Re (WB) and C57BL/6J (B6) inbred strains.
Homozygotes (WBB6F1-nb/nb) for study were obtained by crossing WB
andB6 proven heterozygotes (Bernstein, 1980). Tb remove the effects ofhy-
brid vigor, B6 homozygous (B6-nblnb) mice wereobtained by intercrossing
B6 heterozygotes. WBB6F1-sph/sph mice with a heritable alpha spectrin
deficiency but a normal ankyrin genotype (Bodine et al., 1984) and phenyl-
hydrazine-treated (Sigma P7126, Sigma Chemical Co., St. Louis, MO)
(Chiu et al., 1980) anemic B6-+/+ mice were used as controls. Phenyl-
hydrazine treatment increased the peripheral blood reticulocytes to >95%
and caused erythroid hyperplasia of the spleen.
Ankyrin Nomenclature
Ithas been agreed upon by the respective mouse and humangene nomencla-
ture committees that ankyrin genes will be named according to the order
in which they are mapped. The homologous genes in each species will be
given the same number. However, slightly different conventions prevail in
the use of italics and upper versus lower case letters in naming the mouse
and human genes. As an example, the symbols for the first ankyrin gene
mapped are Ank1 in mouse and ANKI in human. In this report, we have
chosen to utilize the murine gene symbol to designate the protein: Ank-1
for isoforms derived from the Ank-1/ANKI loci on mouse and human chro-
mosome 8 and Ank-2 for isoforms derived from the Ank-2/ANK2 loci on
mouse Chromosome 3/human chromosome 4.
ImmunoblotAnalysis ofReticulocyte Ghosts
Hemoglobin-depleted ghosts were prepared from adult B6-+/+ and
WBB6F1-nb/nb mice by repeated lysis in 5 mM sodium phosphate, pH 7.6,
containing 1 mM diisopropyl fluorophosphate, 1 mM Na2 EDTA and 50
mM Ep475 (E-64C) ('Ikmai et al., 1981). The Ep475 was a gift from Dr.
A. L. Goldberg (Harvard Medical School). SDS-PAGE was performed
according to the method of Laemmli (1970) using a 5 % stacking/10% run-
ning gel. Protein concentration was determined by the method of Lowry
(1951). The separated proteins were transferred in a semi-dry transfer
apparatus (Bio-Rad Trans Blot SD; Bio-Rad Laboratories, Oxnard, CA)
to Immobilon P in 48 mM Tris-HCI, 39 mM glycine, pH 9.2, with 20%
methanol. Ankyrin was detected using an affinity-purified anti-human
erythrocyte ankyrin IgG kindly provided by Dr. Panos Savvides (Harvard
Medical School) and horseradish peroxidase conjugated Protein G (Bio-
Rad) as described previously (Peters et al., 1990) .
HybridizationProbes
The probe used to detect Ank1 transcripts was a 4.6-kb cDNA (mAnk-1)
isolatedby Drs. Sam Lux and RobertWhite (Harvard Medical School) from
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a size-selected (>2.0 kb) anemic mouse spleen lambda gtlI cDNA library
kindly provided by Dr. Ron Kopito (Department of Biology, Stanford
Univ.). The mAnk-1 cDNA probe extends from the carboxy end of the
89-kD domain of erythroid ankyrin (Lux et al., 1990b; Lambert et al.,
1990) into the 3' untranslated region. Ank-2 transcripts were detected using
a 2.0 kb human brain ankyrin (hBrank-2) cDNA isolated from a human
brain stem lambda gtll cDNA library by Dr. Edward Otto (Otto et al., .
1991). This clone is distinct, by sequence, from mAnk-1.
Northern Blots
Total cellular RNA was isolated from spleen, bone marrow, peripheral
blood, and PBS-perfused brain by the acid guanidinium-thiocyanate-phenol-
chloroform method (Chomczynski and Sacchi, 1987) . Polyadenylated RNA
(poly(A)+RNA) was isolated by oligo(dT)-cellulosechromatography (Aviv
and Leder, 1972). RNA was fractionated by formaldehyde-agarose gels and
transferred to nylon filters (Sambrook et al., 1989). Probes were 32P_
labeled by the random hexamer priming method (Feinberg and Vogelstein,
1983). Hybridizations were as recommended for Zetabind nylon filters
(AMF CUNO, Meriden, CT) except that the SDS concentration was in-
creased to 0.5% . After hybridization, filters were washed and exposed to
Kodak XAR-5 film at -70°C with an intensifying screen.
Genetic Mapping
A TagI restriction fragment length polymorphism detected by hBrank-2 was
typed in 99 progeny from an interspecific backcross between the B6 and
Musspretus strains ofmice (Nadeau, 1989; Botstein etal., 1980; Southern,
1975). Nylon filter blotsof restrictionenzyme-digestedgenomic DNA from
the backcross progeny were provided by Ceci et al. (1990) and hybridized
in our laboratory. Map distances were calculated as number of crossovers,
divided by number of progeny tested, times 100, and reported as map units
(mean t SEM).
Immunocytochemistry andIn SituHybridization
Mice (2-3 mo old) were anesthetized with avertin and perfused through the
left ventricle with 20 ml PBS (Gibco 310-4200AG, pH 7.4; Gibco Laborato-
ries, GrandIsland, NY) followed by 20 ml cold (4°C) 4% paraformaldehyde
in PBS. The cerebellum was removed and immersed in fresh 4% parafor-
maldehyde for 4 h at 4°C. The tissues were routinely processed to paraffin,
cut at 8 /Lm, and mounted on baked (180°C overnight) poly-L-lysine-coated
slides. Slides were deparaffinized, dehydrated, air dried, and stored dessi-
cated at -70°C.
For immunocytochemistry, an antibody was prepared (VB) using the
ANK-1 specific human sequence, which is spliced out to convert ankyrin
2.1 to activated ankyrin 2.2 (Lambert et al., 1990; Lux et al ., 1990b).
Three different peptides (15 residues each) corresponding to this ANK-1
specific insert were prepared and conjugated to glutaraldehyde-activated
rabbit serum albumin and all three peptides were used for immunization.
The antibody was affinity-purified on a human ankyrin 2.2 column to re-
move cross reactivity to other ankyrin epitopes and on a sheep ankyrin 2.1
column to obtain anantibody that both reacts with intact protein and cross-
reacts with other species.
To detect ANK-1 in brain sections, endogenous peroxidase activity was
blocked by incubating deparaffinized slides two times in 3 % hydrogen
peroxidein absolutemethanol for 15 min each. Nonspecificprotein binding
was blockedby incubation in PBScontaining 10% ovalburnin (Fisher A388-
500) for 30 min. Slides were incubated with ANK-1 specific antibody
diluted 1/250 in PBS containing 1% BSA (Sigma A7630) at 37°C in a hu-
midified chamber overnight. After two washes in PBS, antibody binding
was detected by the immunoperoxidase reaction using the ABC Vector sys-
tem (PK4001; Vector Laboratories, Inc., Burlingame, CA) .
To detect ankyrin messages, slides were incubated in proteinase K (2 ug/
ml) (BRL Laboratories, Gaithersburg, MD) in PBS for 20 min at 37°C,
washed in PBS and incubated overnight at 42°C in a humidified chamber
in hybridization solution: 2x SSC (0.3 M sodium chloride, 0.03 M sodium
citrate), 0.1 M sodiumphosphate (pH 6.5), 1 x Denhardt's, 10% dextransul-
fate, 0.05% sonicated herring sperm DNA and 50% formamide with 500
ng/ml mAnk-1 probebiotinylated using the BRLBio Nick system (8247SA).
Forcontrols, nick translatedbiotinylated pBR322 was used as the hybridiza-
tion probe. The slides were rinsed twice in 2 x SSC-0.1% SDS and 0.2x
SSC-0.1% SDS at room temperature followed by two 15-min washes in
0.2x SSC-0.1% SDS at 50°C. The sections were rinsed in buffer (0.1 M
Tris-HCL, pH 7.5, 0.1 M NaCl, 2 MM MgC12, 0.05% Triton X-100) and
blocked for 20 min at 42°C in buffer containing 3% BSA. Biotinylated
1234probe was detected with streptavidin-biotin (alkaline phosphatase con-
jugate) and visualized with nitro-blue tetrazolium/5-bromo-4-chloro-3-
indolyl phosphate using a commercial kit (BRL 8239SA) .
Histopathology
Mice were anesthetized with avertin, perfused through the left ventricle
with 20 ml ofBouin's fixative, and immersed overnight in 500 ml ofBouin's.
The next day, the cerebellum was removed and routinely processed to
paraffin . Serial sections were cut at 8 Wm, stained with luxol fast blue, and
counterstained with cresyl violet . Purkinje cell density was determined by
counting the cells in random fields along the Purkinje cell layer using a
calibrated ocular scale. Results were expressed as numberof Purkinje cells
per millimeter . After the Purkinje cell counts were completed, all fields
were carefully examinedto determine ifany pathological changes restricted
to particular anatomical sites within the cerebellum were present .
Results
TheAnk-1 Protein Is Present butMarkedlyReduced
in nblnb Cells
Previously, we showed by Western blot analysis that there are
small amounts of a 150-kD erythroid ankyrin bound to the
cell membrane of nb/nb reticulocytes but we were unable to
detect the normal-sized 210-kD Ank-1 (White et al., 1990) .
By inclusion in the lysis buffer ofthe additional protease in-
hibitors, DFP and Ep 475, and by use of the more efficient
semi-dry transfer system and enhanced protein binding to
Immobilon P, we demonstrate the presence of 210 kD Ank-1
in nblnb ghosts (Fig . l, lane 2) . By comparison with the nor-
mal Ank-l-reactive species in lane 1, it is clear that the mu-
tant Ank-1 is markedly reduced and that the 150-kD Ank-1
is unique to the mutant adult reticulocytes . Kordeli and Ben-
nett (1991) in a companion paper show by Western blotting
that Ank-1 protein is present but markedly reduced in nblnb
brain, whereas Ank-2 is present at normal levels .
Multiple Transcripts oftheAnk-1 Gene
Are Expressed in Normal Erythroid TissuesandAre
Deficient in nblnb Erythroid Tissues
To establish the effects of the nb mutation onAnkl mRNAs,
we first compared theRNA species isolated from normal and
nblnb erythroid cells and tissues . Fig . 2 shows the results ob-
tainedwhenRNA filter blots of poly(A)+RNA from normal
and nblnb erythroid tissues are probed with 32P-labeled
Ank-1 cDNA (mAnk-1) . Two transcripts, -7.5 and 9.0 kb are
detected in spleen and reticulocyte poly(A)+RNA from nor-
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Figure 1. Immunoblot ofhemo-
globin-depleted ghosts (100 hg)
from B6-+/+ (lane 1) and
WBB6F1-nb/nb (lane 2) mice
probed with anti-human eryth-
rocyte ankyrin. In nblnb mice,
normal (210 kD) Ank-1 is se-
verely reduced and a truncated
150-kD immunoreactive protein
is present .
Figure 2 . Autoradiograms ofRNA filter blots hybridized to 32p
labeled erythroid ankyrin probe, mAnk-1 . Lane 1, 5 lAg B6-+/+
spleen poly(A)+RNA ; lane 2, 5 lug WBB6F1-nb/nb spleen
poly(A)+RNA ; lane 3, 5 ug B6 +/+ reticulocyte poly(A)+RNA ;
lane 4, 5 pg WBB6Fl-nb/nb reticulocyte poly(A)+RNA ; lane 5, 10
/zg B6-+/+ bone marrow totalRNA ; lane 6, 10 leg WBB6F1-nb/nb
bone marrow total RNA . Band sizes in kilobases were determined
relative to 18 and 28S RNA .
mal B6 mice with a phenylhydrazine induced anemia (lanes
1 and 3) . There are tissue specific differences in the relative
amounts of7.5 and 9.0 kb expressed . In spleen and bone mar-
row the ratio of 7.5 and 9.0 kb is -2:1 (lanes 1 and 5),
whereas in reticulocytes only trace amounts of the 9.0-kb
mRNA are expressed (lane 3) . In the nblnb tissues, the 7.5-
and 9.0-kb transcripts are greatly reduced (<25% of normal)
(lanes 2 and 4) or not detectable (lane 6) by this method .
Confirmation ofthe decrement in mutantmRNA species was
established independently by quantitative dot blot methods
(Sweetser et al ., 1988 ; Thurston and Saffer, 1989) (data not
shown) . The nblnb transcripts appear to be normal or near
normal sized and to be expressed in the same relative propor-
tions as the normal transcripts . Results show the reduction
in mutantAnk1 mRNA levels correlates with the Ank-1 pro-
tein deficiency noted above in erythroid cells .
Ank1 Gene TranscriptsAre Expressed inNormal
BrainandAre Deficient in nblnb Brain
To determine if the nb mutation has a similar effect on the
brain, RNA filter blot analysis with Ank-1 and Ank-2 cDNA
was performed . With Ank-1 cDNA (Fig . 3), a single tran-
script that comigrates with the 9.0-kb band in spleen RNA
is detected (lanes 1 and 2) . This transcript is expressed at a
much higher level in the cerebellum than in the rest of the
brain (lanes 3 and 4) . As noted in nblnb erythroid tissues,
the level of the 9.0-kb transcript is greatly reduced in nblnb
cerebellum (lanes 5 and 6) .
Fig . 4 shows the three transcripts of -10, 11, and 7.5 kb
Figure 3. Autoradiograms of RNA filter blots hybridized to asp
labeled erythroid ankyrin probe, mAnk-1 . Lane 1, 10 lAg B6 +/+
whole brain total RNA ; lane 2, 5 pg B6-+/+ spleen poly(A)+
RNA ; lane 3, 15 Ag B6-+/+ whole brain minus cerebellum total
RNA ; lane 4, 15 ,ug B6-+/+ cerebellum total RNA ; lane 5, 10 jig
B6 +/+ cerebellumtotalRNA ; lane 6, 10 ug WBB6Fl-nb/nb cere-
bellum total RNA . Band sizes in kilobases were determined rela-
tive to 18 and 28S RNA.
1235Figure 4. Autoradiograms of
RNA filter blots hybridized to
' 2P-labeled brain ankyrin probe,
hBrank-2 . Lane], 15 ug B6-+/+
whole brain total RNA; lane 2,
15 hgWBB6F1-nb/nb whole brain
total RNA . Band sizes in kilo-
bases were determined relative to
18 and 28S RNA .
detected with the Ank-2 cDNA probe (hBrank-2) . Expres-
sion of Ank-2 is normal in nblnb brain (lanes 1 and 2) as
predicted by the results ofKordeli and Bennett (1991) and the
mapping data (below) .
Ank-2 Is Encodedbya Gene on Mouse Chromosome 3
To determine if Ank-2 is linked toAnk1 onChromosome 8,
we mapped Ank-2 . Assignment ofAnk-2 was done by analy-
sis of 99 progeny from the interspecific backcross outlined
in Table I . Nylon-filter blots of TagI restriction enzyme-
digested genomic DNA from backcross progeny were kindly
provided by Ceci et al . (1990) . Hybridization and RFLP
analysis using the Ank-2 probe (hBrank-2) were done at The
Jackson Laboratory. RFLP typing for Anry-2 and Egf was
provided by Ceci et al . (1990) . The results of this analysis
place the Ank-2 locus on the distal end ofmouse Chromo-
some 3, 7.0 + 2 .5 map units distal to the well-defined marker
locus Anry-2 and 3.0 t 1.7 map units proximal to the Egflo-
cus . Human ANK2 has recently been mapped to chromo-
some 4 within the region q25-27 (Tse, W. T., personal com-
munication) . By mapping Ank-2 to the distal end ofmouse
Chromosome 3, we have extended the known homology be-
tween Chromosome 3 and human chromosome 4q .
Ank1 Is Present in Granule CellsandPurkinje Cells
oftheNormal Cerebellum but Is Markedly Reduced in
nblnb Cerebellum
Our hybridization blot analysis described above demon-
TableL Genetic Linkage ofAnk-2 on Chromosome 3
Chromosome inherited from Fl parent
Cross : (C57BL/6J x Mus spretus)F1 x C57BL/6J .
Total progeny tested = 99 . Gene order : Centromere-//-Amy-2-7.0-Ank-2-
3 .0-Egf--- .
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strated a high level of Ank-1 mRNA in the normal cerebel-
lum and severely reduced levels in nblnb cerebellum . We
further investigated Ank-1 distribution by in situ hybridiza-
tion using biotinylated mAnk-1 cDNA as the probe . In nor-
mal cerebellum, Purkinje cells show intense positive signal
(Fig . 5 a) . Granule cells are also positive, although to a
lesser extent . Interestingly, as has been reported previously
for microtubule-associated protein mRNA (Tucker et al .,
1989), hybridization signal is seen in the dendrites extending
into the molecular layer indicating possible local synthesis
of Ank-1 . In nblnb mice, the Ank-1 hybridization intensity
in Purkinje cells is reduced to or near background levels,
there is no evidence of Ank-1 in Purkinje cell dendrites, and
Ank-1 in granule cells is clearly reduced (Fig . 5 b) . Purkinje
cells and their dendrites, as well as granule cells, are nega-
tive when biotinylated pBR322 is used as a probe (data not
shown) .
As a correlate to the in situ hybridization studies, we used
antiserum specific for Ank-1 for immunocytochemical inves-
tigation of normal and nblnb cerebellums . Intense positive
signal is found in the cell bodies of Purkinje cells and within
the granule cell layer of normal mice (Fig . 5 c) . Diffuse
staining within the molecular layer is also present, but
whether this represents labeling of dendrites or axons (or
both) can not be determined at this level . In nblnb cerebel-
lum, signal is markedly reduced in all structures (Fig. 5 d) .
Using this same Ank-1 specific antibody, these results have
been confirmed by both tissue immunofluorescence and West-
ern blotting in nblnb brains (Kordeli and Bennett, 1991) .
AProgressive Loss ofnblnb Purkinje Cells Correlates
with theAge-dependentPsychomotorDisorder
Having demonstrated that there are abnormal levels of Ank1
mRNA and protein in the mutant cerebellum, we sought
pathological changes that would explain the appearance of the
neurological syndrome in these mice . Purkinje cell density
was determined from luxol fast blue/cresyl violet-stained
serial sections of normal (B6), non-ankyrin-deficient but
anemic WBB6F1-sphlsph and B6-nblnb cerebellums. Repre-
sentative sections are shown in Fig . 6. Purkinje cell size,
morphology and number appear normal in nblnb cerebellum
at 6 wk of age (a and b) . However, at 5-7 mo a striking loss
of morphologically normal-appearing Purkinje cells is evi-
dent in B6-nblnb cerebellum (d) when compared to age
matched normal B6 and WBB6F1-sphlsph anemic controls
(c and e) .
Table II presents quantitative data on Purkinje cell density
for control and nblnb cerebellums from 1 to 12mo ofage .By
5-7 mo, the Purkinje cell density in nblnb brains is -50% of
normal . No further loss is noted in mutant mice by 10-12mo
of age . The Purkinje cell loss in nblnb mice occurs in ran-
dom clusters and does not localize to any specific anatomical
area of the cerebellum . The psychomotor disorder is appar-
ent in all B6-nblnb mice by 6 mo ofage. This manifests itself
in an awkward, unbalanced gait and a moderate tremor which
persists even when the animal is at rest . Non-ankyrin-de-
ficient anemic control mice (WBB6F1-sphlsph) do not ex-
hibit neurological effects up to 12 mo of age .
Purkinje cell loss and the appearance ofthe psychomotor
disorder are delayed relative to the Ank-1 mRNA deficiency.
Ank-1 transcripts are already deficient in nblnb cerebellum
at 1 mo of age and there is no further change at 3 and 6 mo
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Map distances
Amy-2 - Ank-2 7.0 t 2.5
Ank-2 - Egf 3.0 f 1 .7Figure5 . Detection of Ank-1 message in B6-+/+ (a) and WBB6F1-nb/nb (b) mice by in situ hybridization using biotinylated mAnk-1 as
probe . Hybridization signal was detected with alkaline phosphatase . No counterstrain was used . Immunocytochemical demonstration of
Ank-1 protein in B6-+/+ (c) and WBB6F1-nb/nb (d) cerebellum using human Ank-l-specific antiserum . Binding was detected with
horseradish-peroxidase . Slides were counterstained with hematoxylin. The Purkinje cell layer (arrows) and, to a lesser extent, the granule
layer (GL) of B6-+/+ mice contain abundant Ank-l protein and Ank-1 mRNA . Diffuse reaction is also seen in the molecular layer (ML)
ofB6-+/+ mice . In nb/nb mice, Ank-1 protein andmessage are markedly reduced in all structures. Bars : (a and b) 50jm ; (c and d) 25 Ftm.
Discussion
This report describes a previously unobserved neurological
component ofthe hemolytic anemia mutation, nb, and corre-
lates Purkinje cell loss with the depletion ofa specific struc-
tural protein, Ank-1 . There is no apparent role of the major
brain ankyrin, Ank-2, in the genesis of the disease . Abun-
dant evidence exists that the nb mutation is a small gene le-
sion restricted totheAnk1 locus and, therefore, thatthe neu-
rological sequelae in nblnb mice are a direct consequence of
Ank-l, erythroid ankyrin, deficiency. First, nb and Ank1
map to the same region of murine Chromosome 8 (White et
al., 1990), and extensive restriction fragment length analysis
has not detected mutation related restriction fragment length
polymorphisms in nblnb genomic DNA (data not shown) .
Second, normal sized Ank-1 protein is present butmuch de-
creased in the mutant reticulocytes . Third, low levels of
Ank-1 mRNA, also of normal size, are detectable in nblnb
reticulocytes, erythro-generative tissues, and cerebellum .
The absence of restriction fragment length polymorphisms
and the presence ofeven small amounts ofapparently normal
sized Ank-1 protein andmRNA in nblnb mice precludes the
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presence ofa large chromosomal deletion, which potentially
could affect other genes, in these mutants .
These data confirm the relationship between nb andAnk1,
but provide only partial evidence that the Ank-1 deficit is
responsible for the neurological manifestations . The marked
reduction of Ank-1 mRNA in the nblnb Purkinje cells by in
situ hybridization and of Ank-1 protein by immunocyto-
chemistry are amore telling argument for the role of Ank-1
in the neurological disease . Kordeli and Bennett (1991) have
recently completed an elegant immunofluorescent study of
ankyrin protein distribution in normal and nblnb neural tis-
sue which confirm our findings concerning nblnb Purkinje
cells . These findings coupled with the dramatic loss ofnblnb
Purkinje cells at the time disease symptoms first appear pro-
vide proofthat Ank-1 is directly involved in the neurodegen-
erative disease. A possible role of the anemic state in the
degeneration is precluded by the use of anemic but Ank-1
normal sph/sph mice as controls .
The interactions of Ank-1 with other cytoskeletal pro-
teins in Purkinje cells are yet to be defined . Immunoreactive
forms ofspectrin have been localized to chicken and rat Pur-
kinjecells (Lazarides and Nelson, 1983 ; Goodman and Zagon,
1237Figure 6 . Luxol fast blue/cresyl-violet-stained tissue sections of normal and anemic cerebellums from mice of different ages . (a) B6-+/+
at 6wk ofage; (b) B6-nblnb at 6wk ofage; (c-e)B6-+/+, B6-nblnb,WBB6F1-sphlsph at 6mo of age. The Purkinje cell layer is indicated
with arrows, GL indicates the granule cell layer . Loss of Purkinje cells at 6 months of age is evident in B6-nblnb mice (d) where only
one apparent Purkinje cell is evident (arrowhead) . Bar, 140 um .
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1238Figure 7 . Autoradiogram of a cerebellar RNA filter blot hybridized
to 32P-labeled erythroid ankyrin probe, mAnk-1 . Lanes 1, 3, and 5,
15 jug total RNA from B6-+/+ cerebellums at 1, 3, and 6 mo of
age ; lanes 2, 4, and 6, 15 ug totalRNA from WBB6F1-nb/nb cere-
bellums at 1, 3, and 6 mo of age . Similar patterns are seen up to
12 mo ofage (data not shown) . Band sizes in kilobases were deter-
mined relative to 18 and 28S RNA .
1985), and an isoform ofBand 3 is present in rat brain (Kay
et al ., 1991) . In addition, we have demonstrated the presence
of erythroid beta spectrin in normal mouse brain by North-
ern analysis (data not shown) . Hence, potential interactions
between Ank-1 and other membrane cytoskeletal proteins in
Purkinje cells are numerous . It is likely that deficiencies in
some of these proteins, particularly spectrin, contribute to
Purkinje cell deterioration in nb/nb mice . Indeed, this is the
case in nb/nb reticulocytes, which accumulate only 50% of
normal spectrin levels (Bodine et al ., 1984) . However, nb/nb
mice are congenic with their normal littermates and differ
only at the nb (Ank1) locus on Chromosome 8 ; reductions
in spectrin, therefore, are a secondary consequence of the
ankyrin deficit .
It is noteworthy that psychomotor disorders are found in
human beings deficient in ankyrin (Coetzer et al ., 1988) and
in cases ofill-defined hereditary spherocytosis and "constitu-
tional hemolytic icterus" (McCann and Jacob, 1976) . In view
of our findings, neurological sequelae in human beings with
some forms ofhereditary spherocytosis may be a direct con-
sequence of Ank-I deficiency. Of particular interest are the
descriptions of patients with HS that, like nb/nb, develop
neurological symptoms later in life which do not exacerbate
with age (McCann and Jacob, 1976) .
TableH . Age-related Purkinje Cell Density in Normal
and Anemic Mice
Peters et al . Erythroid Ankyrin in Purkinje Cells
Each Purkinje cell density value represents the average number of Purkinje
cells per millimeter determined for an individual mouse by counting the num-
ber of Purkinje cells in 100 random fields, 0.375 mm long.
Delayed onset of neurological symptoms is not an unusual
phenomenon inheritable neurological syndromes . In 80% of
mouse mutants with motor neuron degeneration (gene sym-
bol, Mnd), motor neuron loss with onset of symptomatic be-
havior occurs at 7-8 mo of age (Messer et al ., 1987) . Symp-
toms of an autosomal recessive form of spinocerebellar
degeneration in human kindred appear at an average age of
15 yr (Al-Din et al ., 1990) . Autosomal dominant Machado-
Joseph Disease can appear in the fourth and fifth decade
(Suite et al ., 1986), while autosomal dominant adult amyo-
trophic lateral sclerosis appears at 19-46 yr (Veltema et al .,
1990) .
The neurological manifestations of the nb mutation are
reminiscent of other murine mutations characterized by Pur-
kinje cell loss . These include Purkinje cell degeneration
(pcd), lurcher (lc), staggerer (sg), and nervous (nr) (Mullen
et al ., 1976 ; Wetts and Herrup, 1982 ; Herrup and Muller,
1979a ; Wassef et al ., 1987) . In pcd/pcd mice, only 1% of
the Purkinje cells remain by postnatal day 28, yet, as in nb/nb
mice, only a moderate ataxia is seen and this only when Pur-
kinje cell loss reaches 50% (Mulleret al ., 1976) . Inpcd/pcd,
sg/sg and nr/nr mice, regional anatomical differences in Pur-
kinje cell loss occur thus defining, by virtue oftheir response
to the various mutations, subpopulations of Purkinje cells
within the cerebellum (Herrup and Muller, 1976b ; Wassef
et al ., 1987) . The nb mutation is similar to these Purkinje
cell loss mutants in that the mutation appears to affect a sub-
population of Purkinje cells . This subpopulation, however,
is not confined to any specific anatomical area ofthe cerebel-
lum but is, instead, in random clusters throughout the cere-
bellum .
Other sites where Ank-1 are diminished may be present in
nb/nb mice since erythroid ankyrin is widely disseminated
in the central nervous system, including the spinal cord and
peripheral nerves (Kordeli et al ., 1990) . Hence, as is the
case in human spinocerebellar degeneration, systems in ad-
dition to the cerebellum and its neuronal pathways are likely
to contribute to the neurological symptoms of nb/nb mice.
In addition to characterizing the neurodegenerative effects
produced by nb, these studies report, for the first time, the
types and distribution of murine Ank-1 and Ank-2 mRNAs
in the brain and erythroid tissues . Two Ank1 transcripts
(-7.5 and 9.0 kb) are expressed in erythroid tissues of nor-
mal mice . Similar-sized transcripts havebeen reported in hu-
man erythroid tissues (Lambert et al ., 1990) . In the brain,
a single 9.0-kb erythroid ankyrin transcript is present with
expression highest in the cerebellum . The transcripts are
also detected in RNA from erythroid and brain tissues of
nb/nb mice ; however, the level ofthe transcripts in each tis-
sue is dramatically reduced . The sizes of the nb/nb tran-
scripts are in the normal range, but we can not exclude the
possibility that small insertions or deletions have occurred .
These would be difficult to detect on filter blots because of
the large size and low levels of transcripts detected . The
common action of nb on both the erythroid and brain tran-
scripts supports the conclusion that the 9.0-kb transcript in
brain is a product of the Ank1 gene and not the result of
cross-hybridization to a closely related message. In addition,
the data suggest, by the same argument, that the multiple
transcripts detected arise by alternative mRNA processing .
The reduction of Ank-1 nlRNA levels in nb/nb mice with




5-7 mo 10-12 mo
B6 +/+ 38.3 32 .6 32 .9
34.9 30 34.0
36 .3 31 .5
34.2 31 .0
WBB6F 1 35.7 32.6 34.6
sphlsph 36.4 36.9 30.3
37 .4 34.9
35 .9
B6 35 .7 16.2 15.3
nblnb 33 .2 13.5 15.7
31 .9 14.8
32.3presence of a unique (150-kD) form of ankyrin parallel
changes described for the murine spfash mutation (Hodges
and Rosenberg, 1989). Here, a point mutation produces low
levels (10% ofwild type) of normal sized preornithine trans-
carbamylase as well as an aberrant alternatively spliced form
ofthe protein with corresponding low levels of normal length
mRNA . Premature termination oftranslation has been shown
to reduce steady-state mRNA levels in human Beta-thalas-
semia (Baserga and Benz, 1988) and murine muscular dys-
trophy (gene symbol, mdx) (Sicinski et al ., 1989) . The
reduction ofmRNA in the presence of a translatable protein,
such as occurs in s .4`' and nb, is less well documented. In-
deed, Beserga and Benz (1988) showed that no reduction in
mRNA levels occurred when translatable missense muta-
tions were made in the human beta globin gene in vitro.
However, defective RNA processing, such as occurs in hu-
man Beta+-thalassemia (Maquat et al ., 1980) can account
for decreased mRNA levels (Housman et al., 1973).
In both murine and human Beta-thalassemia, there occur
compensatory increases in other types ofglobins encoded by
different genes. For example, fetal gamma (y) globin is in-
creased in humanBeta-thalassemia (Weatherall et al., 1985),
while Betami"or globin is increased in murine Beta-thalas-
semia (Curcio et al., 1987) . Hence, the possibility that the
150-kD protein present innblnbmice is the product ofa gene
related to, but distinct from, Ank1 can not be excluded. The
mechanism of mRNA reduction and the origin ofthe 150-ík1)
protein provide intriguing questions for future studies of the
nb mutation.
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